Tarsus Pharmaceuticals, Inc. TARS Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s shares (diluted)?
- Tarsus Pharmaceuticals, Inc. (TARS) reported shares (diluted) of 43M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s shares (diluted) changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s shares (diluted) increased by 9.2% year-over-year, from 39.3M to 43M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s shares (diluted)?
- Over 4 years (2021 to 2025), Tarsus Pharmaceuticals, Inc.'s shares (diluted) has grown at a 18.2% compound annual growth rate (CAGR), from 85M to 166.1M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.